JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$3.46B |
| 2 |
Microsoft
MSFT
|
+$2.83B |
| 3 |
Eli Lilly
LLY
|
+$2.1B |
| 4 |
Broadcom
AVGO
|
+$1.33B |
| 5 |
Stryker
SYK
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$3.18B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2.39B |
| 3 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.35B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.07B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.04% |
| 2 | Technology | 20.48% |
| 3 | Healthcare | 9.65% |
| 4 | Financials | 9.27% |
| 5 | Consumer Discretionary | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
BCOV
5526
DELISTED
Brightcove, Inc.
BCOV
| $93.1K | ﹤0.01% |
35,933
+5,177
| +17% | +$13.9K |
2016 Q4
28 quarters
|
|
5527
iShares MSCI Netherlands ETF
EWN
$711M
| $93.1K | ﹤0.01% |
2,085
+140
| +7% | +$5.68K |
2021 Q2
10 quarters
|
|
5528
Oportun Financial
OPRT
$393M
| $92.6K | ﹤0.01% |
23,687
+23,447
| +9,770% | +$100K |
2019 Q3
17 quarters
|
|
5529
Townsquare Media
TSQ
$81.7M
| $92.6K | ﹤0.01% |
8,767
+1,195
| +16% | +$11.3K |
2023 Q2
2 quarters
|
|
5530
iShares MSCI France ETF
EWQ
$348M
| $92.5K | ﹤0.01% |
2,362
-2,506,733
| -100% | -$91.7M |
2022 Q3
5 quarters
|
|
5531
Seres Therapeutics
MCRB
$31M
| $92.4K | ﹤0.01% |
3,301
-3,882
| -54% | -$102K |
2015 Q2
34 quarters
|
|
|
XOMA
5532
DELISTED
Xoma
XOMA
| $92.4K | ﹤0.01% |
4,992
-134
| -3% | -$2.21K |
2019 Q3
17 quarters
|
|
5533
Innovator US Equity Ultra Buffer ETF October
UOCT
$181M
| $92.2K | ﹤0.01% |
+2,848
| New | +$88.9K |
2023 Q4
0 quarters
|
|
5534
Aptus Collared Investment Opportunity ETF
ACIO
$2.42B
| $91.4K | ﹤0.01% |
2,757
-1,202
| -30% | -$38K |
2022 Q4
4 quarters
|
|
|
KWY
5535
Kingsway Corp
KWY
$277M
| $91.3K | ﹤0.01% |
10,872
+3,972
| +58% | +$30.1K |
2023 Q1
3 quarters
|
|
|
MACK
5536
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $91K | ﹤0.01% |
6,789
+2
| +0% | +$25 |
2023 Q2
2 quarters
|
|
5537
HireQuest
HQI
$275M
| $90.8K | ﹤0.01% |
5,916
+1,942
| +49% | +$29.7K |
2021 Q2
10 quarters
|
|
|
CONXW
5538
DELISTED
CONX Corp. Warrant
CONXW
| – | – |
0
| – | – |
2022 Q1
7 quarters
|
|
|
SAND
5539
DELISTED
Sandstorm Gold
SAND
| $90.3K | ﹤0.01% |
17,952
-674,952
| -97% | -$3.22M |
2022 Q3
5 quarters
|
|
|
MOND
5540
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $90.2K | ﹤0.01% |
32,680
+2,294
| +8% | +$8.17K |
2023 Q2
2 quarters
|
|
5541
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$609M
| $89.8K | ﹤0.01% |
+7,867
| New | +$83.6K |
2023 Q4
0 quarters
|
|
5542
ClearShares Piton Intermediate Fixed Income ETF
PIFI
$95.5M
| $89.2K | ﹤0.01% |
965
+72
| +8% | +$6.51K |
2023 Q3
1 quarter
|
|
5543
Xtrackers USD High Yield Corporate Bond ETF
HYLB
$3.34B
| $89.2K | ﹤0.01% |
2,510
+35
| +1% | +$1.2K |
2018 Q3
21 quarters
|
|
5544
Global X MSCI Norway ETF
NORW
$91M
| $89.2K | ﹤0.01% |
3,500
| – | – |
2022 Q4
4 quarters
|
|
|
SBT
5545
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $89.1K | ﹤0.01% |
15,437
+125
| +0.8% | +$719 |
2018 Q1
23 quarters
|
|
5546
The Joint Corp
JYNT
$106M
| $88.7K | ﹤0.01% |
9,230
| – | – |
2019 Q1
19 quarters
|
|
5547
Precision BioSciences
DTIL
$175M
| $88.6K | ﹤0.01% |
8,094
-5,674
| -41% | -$61.2K |
2019 Q1
19 quarters
|
|
5548
CALL
Harley-Davidson
HOG
$2.6B
| $88.4K | ﹤0.01% |
2,400
| – | – |
2022 Q4
4 quarters
|
|
5549
Aveanna Healthcare
AVAH
$2.77B
| $88.3K | ﹤0.01% |
32,953
+396
| +1% | +$755 |
2021 Q2
10 quarters
|
|
|
EARN
5550
Ellington Residential Mortgage REIT
EARN
$152M
| $88.2K | ﹤0.01% |
14,393
+14,384
| +159,822% | +$84.8K |
2020 Q2
14 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2023 Portfolio in Review
As of Q4 2023, JP Morgan Chase held 8,129 positions worth $1.04T, up 15% from $906B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase's Q4 2023 filing shows 701 new, 3,661 increased, 2,247 reduced and 617 closed positions. Its largest new stake was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M. The largest sale was Vanguard S&P 500 ETF, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q4 2023 buy was JPMorgan US Tech Leaders ETF: 3,149,069 shares worth $185M.
- JP Morgan Chase added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023, an estimated $3.46B increase.
- JP Morgan Chase's biggest Q4 2023 reduction was Vanguard S&P 500 ETF, cutting an estimated $3.18B.
- JP Morgan Chase fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
- JP Morgan Chase's ten largest holdings make up 20% of its $1.04T portfolio in Q4 2023.
- JP Morgan Chase opened 701 new positions and closed 617 in Q4 2023.
- JP Morgan Chase's portfolio value rose 15% quarter-over-quarter to $1.04T.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.